Epilepsia Journal Reviews

Fresh from the newsstand, “Epilepsia, the official journal of the International League Against Epilespy,” brings you a stimulating, high-impact mixture of original peer reviewed articles, brief communications, editorial commentaries and more.

CURRENT SUBSCRIBERS to Epilepsia can “pair” their device with their personal or institutional subscription to enjoy full access in this iPad edition.

Epilepsia subscriptions automatically renew within 24 hours of the end of your subscription period for $599.99 (US) unless auto-renew is turned off at least 24 hours before the end of the subscription period.

The journal presents subscribers with scientific evidence and clinical methodology in clinical neurology, neurophysiology, molecular biology, neuroimaging, neurochemistry, neurosurgery, pharmacology, neuroepidemiology, and therapeutic trials.

Note that subscriptions cannot be cancelled during the term of the subscription, but you can still turn off auto-renew to prevent automatic renewal of your subscription.

Epilepsia is the leading, most authoritative source for current clinical and research results on all aspects of epilepsy.

Its goals are to advance and disseminate knowledge about epilepsy, promote research, education and training and improve services and care for patients, especially by prevention, diagnosis and treatment.

Note that any unused portion of a free trial period, if offered, will be forfeited when you purchases a subscription.

Epilepsia is the official journal of the International League Against Epilepsy.

SUBSCRIBE IN THE APP: Annual Subscriptions (12 issues) for the iPad-only edition are available for $599.99 (US) per year.

The leading epilepsia journal is now available on your iPad and iPhone.

To turn off auto-renew, go to your iTunes account settings after purchase.

- Stay current with the latest articles through Early View.

- Save your favorite articles for quick and easy access.